Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02840409
Title Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Hospital for Sick Children
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NZL | CAN | AUS


No variant requirements are available.